These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 33600451)

  • 21. Yellow fever risk assessment in the Central African Republic.
    Ramos Junior AN; Heukelbach J
    Trans R Soc Trop Med Hyg; 2015 Apr; 109(4):231-2. PubMed ID: 25732754
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Global yellow fever vaccination coverage from 1970 to 2016: an adjusted retrospective analysis.
    Shearer FM; Moyes CL; Pigott DM; Brady OJ; Marinho F; Deshpande A; Longbottom J; Browne AJ; Kraemer MUG; O'Reilly KM; Hombach J; Yactayo S; de Araújo VEM; da Nóbrega AA; Mosser JF; Stanaway JD; Lim SS; Hay SI; Golding N; Reiner RC
    Lancet Infect Dis; 2017 Nov; 17(11):1209-1217. PubMed ID: 28822780
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Eliminate Yellow fever Epidemics (EYE): a global strategy, 2017–2026.
    Wkly Epidemiol Rec; 2017 Apr; 92(16):193-204. PubMed ID: 28429585
    [No Abstract]   [Full Text] [Related]  

  • 24. Yellow fever: a decade of reemergence.
    Robertson SE; Hull BP; Tomori O; Bele O; LeDuc JW; Esteves K
    JAMA; 1996 Oct; 276(14):1157-62. PubMed ID: 8827969
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epidemiological monitoring of the last outbreak of yellow fever in Brazil - An outlook from Portugal.
    Selemane I
    Travel Med Infect Dis; 2019; 28():46-51. PubMed ID: 30583006
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Yellow fever in Africa and the Americas, 2014.
    Wkly Epidemiol Rec; 2015 Jun; 90(26):323-34. PubMed ID: 26121768
    [No Abstract]   [Full Text] [Related]  

  • 28. Yellow fever vaccination in the Americas.
    Bull Pan Am Health Organ; 1984; 18(2):188-92. PubMed ID: 6207882
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Management and control of yellow fever virus: Brazilian outbreak January-April, 2018.
    Callender DM
    Glob Public Health; 2019 Mar; 14(3):445-455. PubMed ID: 30122143
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Yellow fever in the WHO African and American Regions, 2010.
    Wkly Epidemiol Rec; 2011 Aug; 86(34):370-6. PubMed ID: 21853629
    [No Abstract]   [Full Text] [Related]  

  • 31. The Public Health Benefits and Economic Value of Routine Yellow Fever Vaccination in Colombia.
    Kieffer A; Hoestlandt C; Gil-Rojas Y; Broban A; Castañeda-Cardona C; Rosselli D
    Value Health Reg Issues; 2019 Dec; 20():60-65. PubMed ID: 30974312
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Yellow fever: an emerging threat for Kenya and other east African countries.
    Sanders EJ; Tukei PM
    East Afr Med J; 1996 Jan; 73(1):10-2. PubMed ID: 8625854
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Yellow Fever: A Perennial Threat.
    Tuells J; Henao-Martínez AF; Franco-Paredes C
    Arch Med Res; 2022 Nov; 53(7):649-657. PubMed ID: 36404585
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Estimating the number of unvaccinated Chinese workers against yellow fever in Angola.
    Wilder-Smith A; Massad E
    BMC Infect Dis; 2018 Apr; 18(1):185. PubMed ID: 29665797
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The impact of a prolonged ebola outbreak on measles elimination activities in Guinea, Liberia and Sierra Leone, 2014-2015.
    Masresha BG; Luce R; Weldegebriel G; Katsande R; Gasasira A; Mihigo R
    Pan Afr Med J; 2020; 35(Suppl 1):8. PubMed ID: 32373259
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The fourth horseman: The yellow fever].
    Vallejos-Parás A; Cabrera-Gaytán DA
    Rev Med Inst Mex Seguro Soc; 2017; 55(2):230-232. PubMed ID: 28296373
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Yellow fever urban outbreak in Angola and the risk of extension.
    Wkly Epidemiol Rec; 2016 Apr; 91(14):186-92. PubMed ID: 27066610
    [No Abstract]   [Full Text] [Related]  

  • 38. Infectious disease. Resurgence of yellow fever in Africa prompts a counterattack.
    Roberts L
    Science; 2007 May; 316(5828):1109. PubMed ID: 17525307
    [No Abstract]   [Full Text] [Related]  

  • 39. The response to re-emergence of yellow fever in Nigeria, 2017.
    Nwachukwu WE; Yusuff H; Nwangwu U; Okon A; Ogunniyi A; Imuetinyan-Clement J; Besong M; Ayo-Ajayi P; Nikau J; Baba A; Dogunro F; Akintunde B; Oguntoye M; Kamaldeen K; Fakayode O; Oyebanji O; Emelife O; Oteri J; Aruna O; Ilori E; Ojo O; Mba N; Nguku P; Ihekweazu C
    Int J Infect Dis; 2020 Mar; 92():189-196. PubMed ID: 31935537
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Notes from the Field: Knowledge, Attitudes, and Practices Regarding Yellow Fever Vaccination Among Men During an Outbreak - Luanda, Angola, 2016.
    Marlow MA; Pambasange MA; Francisco C; Receado OD; Soares MJ; Silva S; Navarro-Colorado C; Zielinski-Gutierrez E
    MMWR Morb Mortal Wkly Rep; 2017 Feb; 66(4):117-118. PubMed ID: 28151922
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.